Advertisement
Population Health and Medical Research Resources
High-Risk Populations
General Resources
- COVID-19 Infection Rates High in Pregnant Women, UW Health Study Finds (Feb. 16, 2021)
- Extra Precautions for Groups and Higher Risk of Severe Illness
Source: Centers for Disease Control and Prevention
- COVID-19 Vaccine Education and Equity Project
- The Impact of Telehealth on Health Equity from the Perspectives of Large Health Systems (CDC Webinar Dec. 8, 2020)
- NIH Research Targets Communities Hardest Hit by COVID-19 (Sept. 16, 2020) Source: National Institutes of Health
- CDC Study Shows Disproportionate Impact on American Indian/Alaskan Native Populations (August 19, 2020)
- Racial Health Disparities and COVID-19 – Caution and Context
July 16, 2020
Source: New England Journal of Medicine - American Indian Reservations and COVID-19: Correlates of Early Infection Rates in the Pandemic
July 2020
Source: Public Health Management and Practice - Reaching the Hispanic Community About COVID-19 Through Existing Chronic Disease Prevention Programs
June 25, 2020
Source: Preventing Chronic Disease - Improving Health Equity for Black Communities in the Face of Coronavirus Disease
June 23, 2020
Source: Public Health Open Journal - HHS Grants Morehouse School of Medicine $40 Million to Combat COVID-19 in Vulnerable Communities
June 23, 2020
Source: U.S. Department of Health and Human Services - Loyola Medicine Case Study: Established Community Partnership Pays Off During COVID-19
June, 2020
Source: American Hospital Association - Study Shines Light on COVID-19 Racial Disparities
May 21, 2020
Source: Sutter Health - Study on effective COVID-19 communications in vulnerable minority communities
May 18, 2020
Source: Mayo Clinic - Anti-Asian Sentiment in the United States – COVID-19 and History
May 16, 2020
Source: The American Journal of Surgery - COVID-19 and Racial and Ethnic Disparities
May 11, 2020
Source: JAMA Network - Racial Disparities in the Time of COVID-19
May 4, 2020
Source: Michigan Medicine - Coronavirus in African Americans and Other People of Color
April 20, 2020
Source: Johns Hopkins Medicine - Detailed Demographic Data Crucial to Effective Coronavirus Response
April 21, 2020
Source: Pew Charitable Trusts - Communities of Color at Higher Risk for Health and Economic Challenges Due to COVID-19
April 7, 2020
Source: Kaiser Family Foundation - National Institute of Minority Health and Health Disparities Funding Opportunities
- Guidance for Older Adults
Source: Centers for Disease Control and Prevention - Coronavirus and COVD-19: Caring for the Elderly
Source: Johns Hopkins Medicine - COVID-19 Information Hub
Source: American Geriatrics Society
Vaccines and Therapeutics
National Institutes of Health
- COVID-19 Therapeutics Prioritized for ACTIV Clinical Trials
- NIH Launches New Initiative to Study “Long COVID” (Feb. 23, 2021)
- Four Potential COVID-19 Therapeutics Enter Phase 2/3 Testing (Feb. 12, 2021)
- Clinical Trial in Hospitalized COVID-19 Patients Evaluates Long-Acting Antibody Therapy (Feb. 8, 2021)
- Janssen COVID-19 Vaccine Phase 3 Clinical Data Released (Jan. 29, 2021)
- NIH Launches Database to Track Neurological Symptoms (Jan. 26, 2021)
- Large Clinical Trial will Test Combination Monoclonal Antibody Therapy for Mild/Moderate COVID-19 (Jan. 5, 2020)
- Peer-reviewed Report Published in NEJM on Moderna COVID-19 Vaccine (Dec. 30, 2020)
- Activ-3 Monoclonal Antibody not Efficacious in Phase 3 Trial (Dec. 22, 2020)
- Investigational COVID-19 Therapeutics to be Evaluated in Large-Scale Clinical Trials (Dec. 17, 2020)
- Baricitinib Plus Remdesiver Shows Promise for Treating COVID-19 (Dec. 11, 2020)
- New Tool Helps Organizations Plan COVID-19 Testing (Dec. 7, 2020)
- New Tool Helps Organizations Plan COVID-19 Testing (Dec. 7, 2020)
- NIH Expands Research to Improve COVID-19 Testing in Underserved Populations (Nov. 20, 2020)
- Moderna’s COVID-19 Vaccine Shows Promising Interim Results (Nov. 16, 2020)
- Hydroxychloroquine Does Not Benefit Adults Hospitalized with COVID-19 (Nov. 9, 2020)
- NIH scientists discover key pathway in lysosomes that coronaviruses use to exit cells (Oct. 28, 2020)
- Large Clinical Trial Begins to Test Immune Modulators for Treating COVID-19 (Oct. 16, 2020)
- NIH Study to Identify COVID-19 Treatments for Large Clinical Trials (Oct. 13, 2020)
- Clinical Trial Begins for Hyperimmune Intravenous Immunoglobulin Plus Remdesivir (Oct. 8, 2020)
- NIH RADx Initiative Advances Six New COVID-19 Testing Technologies (Oct. 6, 2020)
- Moderna Phase I Clinical Trial Generates Strong Immune Response in Older Adults (Sept. 29, 2020)
- Phase 3 Clinical Trial of Janssen Pharmaceutical’s Vaccine Candidate Begins in U.S. (Sept. 23, 2020)
- NIH Expands Clinical Trials for Convalescent Plasma Against COVID-19 (Sept. 22, 2020)
- NIH Awards Contracts to Develop Innovative Digital Health Technologies for COVID-19 (Sept. 15, 2020)
- NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19 (Sept. 10, 2020)
- NIH Awards $129.3 Million to Expand Point-of-Care Testing (Sept. 2, 2020)
- Phase 3 Clinical Testing of AstraZeneca Vaccine Candidate Begins (Aug. 31, 2020)
- Two Phase 3 Clinical Trials of Monoclonal Antibodies Now Enrolling (Aug. 10, 2020)
- Clinical Trial Begins on Merck’s Remdesivir Plus Interferon Beta-1a (Aug. 6, 2020)
- Phase 3 Clinical Trial to Test Eli Lilly Antibodies for Hospitalized COVID-19 Patients (Aug. 4, 2020)
- Phase 2 Clinical Trial to Test Synthetic Antibodies for Mild or Moderate COVID-19 (Aug. 4, 2020)
- NIH Investing $247.8 Million in New COVID-19 Testing Technologies (July 31, 2020)
- Moderna’s Experimental Vaccine Protects Upper and Lower Airways in Nonhuman Primates (July 28, 2020)
- Phase 3 Clinical Trial of Moderna Investigational Vaccine Begins (July 27, 2020)
- Experimental COVID-19 Vaccine Safe, Generates Immune Response (July 14, 2020)
- NIH Launches Clinical Trials Network to Test COVID-19 Vaccine (July 8, 2020)
- Experts Identify Steps to Expand and Improve Antibody Tests (June 23, 2020)
- All of Us Research Program Launches COVID-19 Research Initiatives (June 16, 2020)
- National COVID Cohort Collaborative (N3C) to Build Centralized Patient Data Repository (June 15, 2020)
- NIH COVID-19 Resources Page
- Peer-reviewed Data Shows Remdesivir Improves Time to Recovery (May 22, 2020)
- Investigational ChAdOx1 nCoV-19 Vaccine Protects Monkeys Against COVID-19 Pneumonia (May 15, 2020)
- NIAID Strategic Plans Details COVID-19 Research Priorities (April 23, 2020)
- Clinical Trials Related to COVID-19
- Advantages and Trade-offs of COVID-19 Diagnostic Tests
(November 11, 2020)
Sources: National Academies of Science, Engineering, and Medicine - Proposed Framework for Equitable Allocation of Coronavirus Vaccine
(September 8, 2020)
Sources: National Acadamies of Science, Engineering, Medicine - Interim Framework for COVID-19 Vaccine Allocation and Distribution in the U.S.
August 19, 2020
Sources: Johns Hopkins Center for Health Security - Moderna mRNA-1273 Phase I clinical trials induced immune responses in 45 healthy adults age 18 to 45
July 14, 2020
Sources: New England Journal of Medicine - Drug That Calms Cytokine Storm Associated with Lower Risk of Dying for COVID-19 Patients on Ventilators
July13, 2020
Source: Michigan Health - Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients
July 2, 2020
Source: Henry Ford Health System - Dexamethasone reduces death in hospitalized patients with severe respiratory complications of COVID-19
June 16, 2020
Source: University of Oxford - Treatment of COVID-19 Patients With Convalescent Plasma
May 27, 2020
Source: The American Journal of Pathology - Remdesivir for the Treatment of COVID-19--Preliminary Report
May 22, 2020
Source: New England Journal of Medicine
- AstraZeneca [+]
- Emergent Biosolutions Inc. [+]
- Gilead Sciences [+]
- Johnson & Johnson [+]
- Merck Inc. [+]
- Moderna, Inc. [+]
- Pfizer, Inc. [+]
- Sanofi [+]
- Brigham and Women’s Hospital
- Cleveland Clinic
- Hackensack Meridian
- Houston Methodist
- Johns Hopkins:
- Kaiser Permanente
- Mayo Clinic
- Massachusetts General Hospital
- Penn Medicine
- University of Michigan
- Vanderbilt University Medical Center
- Medical Countermeasures Portfolio—Vaccines, Diagnostic Tests, Therapeutics
Source: Biomedical Advanced Research and Development Authority (BARDA) - ASPR’s Portfolio of Medical Countermeasures Under Investigation
Source: HHS Assistant Secretary for Preparedness & Response - COVID-19 Vaccine Tracker
Source: Regulatory Affairs Professional Society
Immunization Programs
Centers for Disease Control and Prevention- NACCHO 1/21/21 Webinar: Understanding Diverse Communities to Support Equitable and Informed COVID-19 Vaccination Decision-Making (Call Recording, Presentation Slides)
- _ Harvard Business Review * : Seven-Part Framework for Overcoming Vaccine Hesitancy (Jan. 15, 2021)
- 10 Things Healthcare Professionals Need to Know about COVID-19 Vaccination Plans (Oct. 14, 2020)
- Vaccination Recommendations During the COVID-19 Pandemic
- Maintaining Childhood Immunizations and Well-Child Care During the COVID-19 Pandemic
- Guiding Principles for Immunization During the COVID-19 Pandemic (March 26, 2020)
- Immunization Action Coalition Resources for Developing Mass Vaccination Clinics
- AD Council: Coronavirus Response Toolkit
- _ New England Journal of Medicine : COVID-19 Vaccine FAQs
- FAQs: COVID-19 Vaccine Distribution for the Disability Community
- Michigan COVID-19 Vaccination Plan (Oct. 16, 2020 draft)
- New York COVID-19 Vaccination Plan (October 2020)
- Guidance on Providing Pediatric Well-Child Care During COVID-19
Source: American Academy of Pediatrics - Getting Adolescent Vaccination Back on Track
Source: National HPV Roundtable
Advertisement